Resolve Stroke is a neurotechnology company developing software-driven ultrasound imaging systems to unlock richer brain physiology data from raw ultrasound signals. The company focuses on transforming ultrasound into a high-information neuroimaging modality capable of addressing currently unmet clinical needs.

Its platform leverages software-defined ultrasound and advanced signal processing to extract substantially more information than conventional ultrasound systems. This approach enables bedside neuro monitoring and opens the path toward novel brain biomarkers that are not accessible through standard imaging workflows.

Resolve Stroke’s technology is positioned for clinical use in acute and critical care settings, with applications ranging from real-time brain monitoring to future diagnostic discovery. The company positions itself at the forefront of next-generation neuroimaging by expanding the clinical and scientific value of ultrasound-based brain assessment.